Glucagon-like peptide 1 receptor agonists for type 2 diabetes, Diabetes Spectrum (2017) With Trulicity, patients may be able to lose some weight, Eli Lilly Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11), Diabetes Care (2021) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial, Lancet Diabetes Endocrinology (2017) Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial, Lancet (2014) Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3), Diabetes Care (2014) Mounjaro prescribing information, Eli Lilly Beyond glycemia: Comparing tirzepatide to GLP-1 analogues, Reviews in Endocrine and Metabolic Disorders (2023) Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial, Lancet Diabetes Endocrinology (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Anyone specifically seeking branded Wegovy should confirm availability directly at Eden's official website
However, these studies are mostly observational , meaning they can show an association, but they do not prove that the medicines directly caused the benefits
Biweekly dosing schedules have not been tested in clinical trials
